Search
Larimar Therapeutics Inc
LRMRAdd to Watchlist
3.640USD
+0.100+2.82%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
378.13MMarket Cap
LossP/E TTM
Larimar Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Larimar Therapeutics Inc is 5.98, ranking 370 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.70, which is -32.88% below the recent high of -1.14 and -828.98% above the recent low of -15.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
